Pharmacogenetics of adverse drug reactions: A pharmacovigilance perspective

Journal of Applied Therapeutic Research

Volumn 6, Issue 3, 2008, Pages 3-8

  Alfirevic, Ana ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

ADRs; Adverse drug reactions; Pharmacogenetics; Pharmacovigilance

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTITHYROID AGENT; ATOMOXETINE; AZATHIOPRINE; CARBAMAZEPINE; CLOZAPINE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRINOTECAN; MEFLOQUINE; MERCAPTOPURINE; NEUROLEPTIC AGENT; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PRIMAQUINE; QUINOLONE DERIVATIVE; SALAZOSULFAPYRIDINE; TAMOXIFEN; TRASTUZUMAB; WARFARIN;

AGRANULOCYTOSIS; BLOOD TOXICITY; BREAST CANCER; DIARRHEA; DNA POLYMORPHISM; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG LABELING; DRUG SURVEILLANCE PROGRAM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GOUT; HEMOLYTIC ANEMIA; HUMAN; LEUKOPENIA; LIVER TOXICITY; LONG QT SYNDROME; MAJOR HISTOCOMPATIBILITY COMPLEX; MYOPATHY; PHARMACOGENETICS; PHENOTYPE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RHABDOMYOLYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TENDINITIS; TENDON RUPTURE; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT;

EID: 77958033465     PISSN: 10292659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19. (Pubitemid 38869995)
2. Davies EC, Green CF, Mottram DR and Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006;31:335-341.
3. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:793-798.
4. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
5. *5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reversetranscriptase inhibitor abacavir. Lancet 2002;359:727-732.
6. Ioannidis JP, Ntzani EE, Trikalinos TA and Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-309.
7. Molokhia M and McKeigue P. EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions. Pharmacogenomics 2006;7:633-638.